APA

Pietropaolo M., Yu S., Libman I. M., Pietropaolo S. L., Riley K., LaPorte R. E., Drash A. L., Mazumdar S., Trucco M. & Becker D. J. (20060307). Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. : Pediatric diabetes.

Chicago

Pietropaolo Massimo, Yu Shui, Libman Ingrid M, Pietropaolo Susan L, Riley Karen, LaPorte Ronald E, Drash Allan L, Mazumdar Sati, Trucco Massimo and Becker Dorothy J. 20060307. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. : Pediatric diabetes.

Harvard

Pietropaolo M., Yu S., Libman I. M., Pietropaolo S. L., Riley K., LaPorte R. E., Drash A. L., Mazumdar S., Trucco M. and Becker D. J. (20060307). Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. : Pediatric diabetes.

MLA

Pietropaolo Massimo, Yu Shui, Libman Ingrid M, Pietropaolo Susan L, Riley Karen, LaPorte Ronald E, Drash Allan L, Mazumdar Sati, Trucco Massimo and Becker Dorothy J. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. : Pediatric diabetes. 20060307.